| Medical and Health Sciences | 2021-2025 | 458 | DE 27 | 99.90 |
| Biological Sciences | 2021-2025 | 371 | DE 19 | 99.61 |
| Dermatology | Lifetime | 59 | DE 13 | 99.57 |
| Immunology | Lifetime | 390 | DE 28 | 99.00 |
| Immunology and Allergy | Lifetime | 531 | DE 52 | 90.27 |
| Immunology | 2021-2025 | 17 | DE 3 | 99.60 |
| Dermatology | 2021-2025 | 16 | DE 7 | 99.79 |
| Immunology and Allergy | 2021-2025 | 98 | DE 13 | 92.62 |
| Pathology and Forensic Medicine | 2021-2025 | 283 | DE 18 | 90.99 |
| Rheumatology | 2021-2025 | 299 | DE 22 | 89.60 |
| Dermatology and Skin Diseases | Lifetime | 76 | DE 17 | 99.53 |
| Psoriasis: Treatment and Pathogenesis | Lifetime | 50 | DE 10 | 99.46 |
| Autoimmune Bullous Skin Diseases | Lifetime | 102 | DE 14 | 98.90 |
| Asthma and respiratory diseases | Lifetime | 502 | DE 38 | 98.82 |
| Allergic Rhinitis and Sensitization | Lifetime | 316 | DE 47 | 98.65 |
| Pharmaceutical studies and practices | Lifetime | 336 | DE 25 | 97.35 |
| Autoimmune and Inflammatory Disorders Research | Lifetime | 540 | DE 37 | 96.73 |
| Food Allergy and Anaphylaxis Research | Lifetime | 471 | DE 55 | 96.90 |
| Spondyloarthritis Studies and Treatments | Lifetime | 363 | DE 27 | 96.49 |
| Contact Dermatitis and Allergies | Lifetime | 811 | DE 109 | 94.33 |
| Dermatology and Skin Diseases | 2021-2025 | 14 | DE 4 | 99.71 |
| Psoriasis: Treatment and Pathogenesis | 2021-2025 | 12 | DE 2 | 99.71 |
| Autoimmune Bullous Skin Diseases | 2021-2025 | 13 | DE 5 | 99.27 |
| Asthma and respiratory diseases | 2021-2025 | 62 | DE 10 | 99.20 |
| Cytokine Signaling Pathways and Interactions | 2021-2025 | 19 | DE 2 | 97.02 |
| Pharmaceutical studies and practices | 2021-2025 | 36 | DE 1 | 96.69 |
| Allergic Rhinitis and Sensitization | 2021-2025 | 78 | DE 16 | 98.73 |
| Food Allergy and Anaphylaxis Research | 2021-2025 | 131 | DE 14 | 96.64 |
| Urticaria and Related Conditions | 2021-2025 | 125 | DE 33 | 94.55 |
| Health Systems, Economic Evaluations, Quality of Life | 2021-2025 | 955 | DE 31 | 93.16 |
| Mast cells and histamine | 2021-2025 | 196 | DE 32 | 86.37 |
| Spondyloarthritis Studies and Treatments | 2021-2025 | 447 | DE 32 | 87.50 |
| Autoimmune and Inflammatory Disorders Research | 2021-2025 | 694 | DE 56 | 86.74 |
| Inflammatory mediators and NSAID effects | 2021-2025 | 249 | DE 9 | 79.27 |
| Cutaneous lymphoproliferative disorders research | 2021-2025 | 752 | DE 73 | 75.54 |
| Contact Dermatitis and Allergies | 2021-2025 | 863 | DE 91 | 69.96 |
| Transgenic Plants and Applications | 2021-2025 | 629 | DE 21 | 61.05 |
| Retinoids in leukemia and cellular processes | 2021-2025 | 656 | DE 31 | 58.64 |
| Medicine and Dermatology Studies History | 2021-2025 | 218 | DE 21 | 58.20 |
